Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P19 - Immunotherapy (Phase II/III Trials) - Previously Treated NSCLC

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      P19.01 - RATIONALE-303 Phase 3 Tislelizumab vs Docetaxel in Previously Treated Advanced NSCLC: China Subgroup Analysis

      00:00 - 00:00  |  Presenter: Yun Fan

      • Abstract

      Loading...

    • +

      P19.02 - Sintilimab Plus Docetaxel in Previously Treated Advanced NSCLC, Updates on Progression-Free and Overall Survival

      00:00 - 00:00  |  Presenter: Zhehai Wang

      • Abstract

      Loading...

  • +

    P21 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - IO

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      P21.01 - Selected ctDNA Panel Gene Sequencing for Neoantigen Discovery and Survival Prediction in Patients With Stage IV Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Feng Ming Spring Kong

      • Abstract

      Loading...

    • +

      P21.02 - Real-World Concordance Between Tumor Mutational Burden From Blood and Tissue in Lung Cancer and Other Cancers

      00:00 - 00:00  |  Presenter: Jewel Park

      • Abstract

      Loading...

  • +

    P22 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Monitoring/Prognosis

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      P22.01 - Personalized ctDNA Assay for MRD Detection and Treatment Response Monitoring in a Patient With Metastatic Lung Cancer

      00:00 - 00:00  |  Presenter: Georges Azzi

      • Abstract

      Loading...

    • +

      P22.02 - Combined Use of CYFRA 21-1, CA125 and CRP Predicts Survival of Metastatic NSCLC Patients With Stable Disease

      00:00 - 00:00  |  Presenter: Namrata S Patil

      • Abstract

      Loading...

    • +

      P22.03 - Role of Circulating Tumor Cell Subpopulations in Operable Non-Small Cell Lung Cancer Diagnosis and Prognosis

      00:00 - 00:00  |  Presenter: Emanuela Fina

      • Abstract

      Loading...

    • +

      P22.04 - Prospective Validation of an Eight Gene mRNA Signature in Plasma for the Diagnosis of Early Stage Lung Cancer

      00:00 - 00:00  |  Presenter: Ana María Giménez Capitán

      • Abstract

      Loading...

    • +

      P22.05 - Dynamic Monitoring of Blood Samples by PEAC Technology for Early-Stage Lung Cancer Patients After Surgery

      00:00 - 00:00  |  Presenter: Yue Pu

      • Abstract

      Loading...

    • +

      P22.06 - Prognostic Value of Circulating Tumor Cells in Patients With Small Cell Lung Cancer Receiving Front-Line Treatment

      00:00 - 00:00  |  Presenter: Haohua Zhu

      • Abstract

      Loading...

  • +

    P23 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Screening and Early Detection

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      P23.01 - Integration of Metabolomics and Transcriptomics to Reveal Metabolic Disorder in Early Lung Cancer for Non-invasive diagnosis

      00:00 - 00:00  |  Presenter: xinrong Jiang

      • Abstract

      Loading...

    • +

      P23.02 - Digital Multiplexed circRNA Analysis From Plasma-Derived Extracellular Vesicles of Lung Cancer Patients 

      00:00 - 00:00  |  Presenter: Carlos Pedraz-Valdunciel

      • Abstract

      Loading...

    • +

      P23.03 - Novel Serum Extracellular Vesicles Based miR-153-3p Biomarker Combined to a Prediction Model for Determining Early-Stage Lung Cancer

      00:00 - 00:00  |  Presenter: Yuxia Deng

      • Abstract

      Loading...

    • +

      P23.04 - Serum Biomarkers Enhance Prognostic Value of Computed Tomography (CT) in Patients With Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Rebecca Gerber

      • Abstract

      Loading...

    • +

      P23.05 - Chromosome 3p22.1 and 10q22.3 Amplification in Different Subtypes of Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Qi Wang

      • Abstract

      Loading...

  • +

    P24 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Targeted Therapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      P24.01 - Turnaround Time and Variant Prevalence of a Blood-based KRAS Test in Patients With NSCLC

      00:00 - 00:00  |  Presenter: Edgardo S Santos

      • Abstract

      Loading...

    • +

      P24.02 - Unique Efficacy of Ensartinib on Different ALK Fusion Subtypes Evaluated by Plasma ctDNA

      00:00 - 00:00  |  Presenter: Tao Wang

      • Abstract

      Loading...

    • +

      P24.03 - Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial

      00:00 - 00:00  |  Presenter: Malinda Itchins

      • Abstract

      Loading...

    • +

      P24.04 - Concordance of Tissue and Cell-Free DNA-Based Next-Generation Sequencing in Patients With Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Misha Tran

      • Abstract

      Loading...

    • +

      P24.05 - Using Liquid Biopsies to Guide First-Line Therapy Decisions in Patients With Metastatic Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Luis E. Raez

      • Abstract

      Loading...

    • +

      P24.06 - Resistance Mechanisms Exploring of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study

      00:00 - 00:00  |  Presenter: Guilan Dong

      • Abstract

      Loading...

    • +

      P24.07 - An Ultra-Sensitive Protocol for ctDNA Mutation Detection With Application in Lung Cancers

      00:00 - 00:00  |  Presenter: Yue Pu

      • Abstract

      Loading...

    • +

      P24.08 - Lung Cancer Diagnosis in Absence of Adequate Tissue Molecular Analysis in Metastatic Disease by NGS Analysis of Plasma cfDNA

      00:00 - 00:00  |  Presenter: Christi M.J. Steendam

      • Abstract

      Loading...

    • +

      P24.09 - Association Between Circulating EGFR Mutant Tumor DNA and Tumor Lesion Glycolysis in Patients with EGFR Mutated Metastatic Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Zhasmina Mihaylova

      • Abstract

      Loading...

    • +

      P24.10 - Identification of ctDNA using MassARRAY Technology in a Cross-Sectional Study of NSCLC Patients

      00:00 - 00:00  |  Presenter: Ken O'Byrne

      • Abstract

      Loading...

    • +

      P24.11 - Cell-Free Tumor DNA (ctDNA) Utility in Detection and Monitoring EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Jason Agulnik

      • Abstract

      Loading...

    • +

      P24.12 - Biomarker Testing for Advanced Lung Cancer by Next-Generation Sequencing in Elderly Patients.

      00:00 - 00:00  |  Presenter: luis Roberto basbus

      • Abstract

      Loading...

    • +

      P24.13 - Circulating Tumor Cells Predict Prognosis Following First-Generation EGFR-TKI Treatment in EGFR- and TP53-Mutant Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: wen gao

      • Abstract

      Loading...

    • +

      P24.14 - Validation of Companion Diagnostics for the Identification of Patients with EGFR Exon20ins NSCLC for Amivantamab Therapy

      00:00 - 00:00  |  Presenter: Timothy Jatkoe

      • Abstract

      Loading...

  • +

    P25 - Locally Advanced Non-Small Cell Lung Cancer - Concurrent Chemotherapy/ Radiotherapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      P25.01 - Efficacy of Weekly Paclitaxel-Bevacizumab Combination in Advanced NSCLC: AVATAX, A Retrospective Multicentric Study

      00:00 - 00:00  |  Presenter: Geoffroy Bilger

      • Abstract

      Loading...

    • +

      P25.02 - Concurrent Chemoradiotherapy With Cisplatin + S-1 for Locally Advanced Non-Small Cell Lung Cancer: IPD Meta-Analysis

      00:00 - 00:00  |  Presenter: Yuri Taniguchi

      • Abstract

      Loading...

  • +

    P26 - Locally Advanced Non-Small Cell Lung Cancer - EGFR Targeted Therapy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      P26.01 - Detecting Oligo-Metastatic/Progressive Disease in Advanced EGFR-Mutant NSCLC: PET/CT and Conventional Imaging Methods

      00:00 - 00:00  |  Presenter: Dayu Xu

      • Abstract

      Loading...

    • +

      P26.02 - A Phase II Trial of Neoadjuvant Osimertinib for Surgically Resectable EGFR-Mutant Non-Small Cell Lung Cancer: Updated Results

      00:00 - 00:00  |  Presenter: Collin M. Blakely

      • Abstract

      Loading...

  • +

    P27 - Locally Advanced Non-Small Cell Lung Cancer - Other & Local Treatment Toxicity

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      P27.01 - Patterns of Care and Outcomes in Clinical T3N0M0 Non-Small Cell Lung Cancer Without Invasion of Other Structures

      00:00 - 00:00  |  Presenter: Matthew Willis Parsons

      • Abstract

      Loading...

    • +

      P27.02 - Associating Cardiac Plaque Accumulation With Cardiac Toxicity and Overall Survival In Locally Advanced Non-Small Cell Lung Cancer 

      00:00 - 00:00  |  Presenter: Andreas Rimner

      • Abstract

      Loading...

    • +

      P27.03 - Increase in Overall Survival for Locally Advanced NSCLC Patients From 2010 to 2018 - A Registry Based Study in Denmark

      00:00 - 00:00  |  Presenter: Peter Meldgaard

      • Abstract

      Loading...

    • +

      P27.04 - Clinical Outcomes for Patients With Stage III NSCLC and STK11 or KEAP1 Genetic Alterations

      00:00 - 00:00  |  Presenter: Sean Maximillian Taasan

      • Abstract

      Loading...

    • +

      P27.05 - High Body Mass Index (BMI) Is Associated With Better Outcomes in Mexican Patients With Advanced Non–Small Cell Lung Cancer (NSCLC) 

      00:00 - 00:00  |  Presenter: Saul Campos-Gomez

      • Abstract

      Loading...

    • +

      P27.06 - Multiscale NSCLC Tumor Growth Knowledge-Based Model Reproduces Tumor-Non-Progression under Gefitinib

      00:00 - 00:00  |  Presenter: Adèle L'Hostis

      • Abstract

      Loading...

    • +

      P27.07 - Pancoast Tumour Presenting as Lower Limb Weakness; Would You Recognise It?

      00:00 - 00:00  |  Presenter: Gaurav Jha

      • Abstract

      Loading...

    • +

      P27.08 - Accurate Positioning Technology for Lung Cancer Radiotherapy

      00:00 - 00:00  |  Presenter: Yaping Xu

      • Abstract

      Loading...

  • +

    P28 - Locally Advanced Non-Small Cell Lung Cancer - Post PACIFIC Use of Durvalumab

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      P28.01 - Real-World Experience (RWE) of Consolidation Durvalumab After Concurrent Chemoradiotherapy (CCRT) In Stage III NSCLC

      00:00 - 00:00  |  Presenter: Yiqing Huang

      • Abstract

      Loading...

    • +

      P28.02 - Beyond PACIFIC: Outcomes and Toxicity According to Durvalumab Dosing Schedule Every 2 versus 4 Weeks

      00:00 - 00:00  |  Presenter: Marie-Hélène Denault

      • Abstract

      Loading...

    • +

      P28.03 - Durvalumab Adjuvant to Chemoradiation for Patients With Locally Advanced Non-Small Cell Lung Cancer: Real World Experience

      00:00 - 00:00  |  Presenter: Vilde Drageset Haakensen

      • Abstract

      Loading...

    • +

      P28.04 - Pneumonitis With Durvalumab Following Concurrent Chemoradiotherapy

      00:00 - 00:00  |  Presenter: Wissam Hanayneh

      • Abstract

      Loading...

  • +

    P29 - Locally Advanced Non-Small Cell Lung Cancer - Radiation Planning and Delivery

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      P29.01 - Deformable vs. Rigid Registration in Evaluating Composite Doses to Central Organs at Risk in Thoracic Reirradiation

      00:00 - 00:00  |  Presenter: David Cooper

      • Abstract

      Loading...

    • +

      P29.02 - Early GLS Changes Detection After Chemoradiation in Locally Advanced NSCLC

      00:00 - 00:00  |  Presenter: Sara Ramella

      • Abstract

      Loading...

    • +

      P29.03 - Thoracic Organs at Risk (OARs) Contouring Variations and Consensus in Radiation Therapy for Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Feng Ming Spring Kong

      • Abstract

      Loading...

    • +

      P29.04 - Treatment Plan Parameters and Toxicity Following Chemoradiotherapy and High-Dose Radiotherapy in Stage III Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Merle I. Ronden

      • Abstract

      Loading...

    • +

      P29.05 - Gross Tumor Volume Contouring Variations in Radiation Therapy of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Feng Ming Spring Kong

      • Abstract

      Loading...

    • +

      P29.06 - Both Endostar and Amifostine Reduced All the Incidence of Pneumonitis Above Grade 2 in Chemoradiotherapy With Locally Advanced NSCLC

      00:00 - 00:00  |  Presenter: Kuifei Chen

      • Abstract

      Loading...

    • +

      P29.07 - A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC

      00:00 - 00:00  |  Presenter: Juan Li

      • Abstract

      Loading...

    • +

      P29.08 - Evaluation of the Prognostic Marker of PD-L1 Expression After Combined Radiochemotherapy in Patients With NSCLC Stage III  

      00:00 - 00:00  |  Presenter: Jan Wagner

      • Abstract

      Loading...